People · Operator
Named in public records as an officer, director or promoter · active 2013–2024 · Medical Devices, Biotechnology, Other Technology, Software / Tech
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| ACTIV Surgical, Inc. | — | Medical Devices | Series C | $86.6M | $240.1M | 2019 |
| Excision BioTherapeutics Inc | — | Biotechnology | Series C | $71.2M | $338.5M | 2021 |
| KlearNow Corp | — | Other Technology | Series C | $50.0M | $1.0B | 2021 |
| Reflektion, Inc. | — | Other Technology | Series B | $34.5M | $552.5M | 2013 |
| Linus Biotechnology Inc. | — | Biotechnology | Series B | $31.6M | $42.5M | 2022 |
| Even Financial, Inc. | — | Other Technology | Series B | $25.1M | $578.3M | 2018 |
| Insight Rx, Inc. | — | Other Technology | Seed | $3.3M | $110.7M | 2017 |
| Cognitive Operational Systems, Inc. | — | Software / Tech | Pre-Seed | $1.4M | $23.3M | 2017 |
Ashok Krishnamurthi at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Ashok Krishnamurthi on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Babak Yazdani | 1 | 18 |
| Paul Meister | 1 | 12 |
| Amol Deshpande | 1 | 8 |
| Rajeev Madhavan | 1 | 6 |
| Vasudev Bailey | 1 | 5 |
| David Wells | 1 | 4 |
| Will Cowen | 1 | 4 |
| PETER KIM | 1 | 4 |
| NISHITA CUMMINGS | 1 | 4 |
| Rafi Syed | 1 | 3 |
| Brendan Dickinson | 1 | 3 |
| S. Atiq Raza | 1 | 2 |
| Michael Ruehlman | 1 | 2 |
| Todd Usen | 1 | 2 |
| William Carson | 1 | 2 |
| David H. Wells | 1 | 2 |
| Jonas Cleveland | 1 | 1 |
| Kostas Daniilidis | 1 | 1 |
| Edward Henkler | 1 | 1 |
| Manish Arora | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.